Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OSBP | P22059 | 1/20 | 0.32 |
| ▸ | OSBP2 | Q969R2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9785228 | 0.98 | OSBP (0.33) | OSBPOSBP2MEN1KMT2A | |
| SCHEMBL16411045 | 0.93 | OSBP (0.33) | OSBPOSBP2MEN1KMT2A | |
| SCHEMBL17667196 | 0.90 | CA1 (0.31) | — | |
| SCHEMBL14511538 | 0.86 | OSBP (0.31) | OSBPOSBP2 | |
| SCHEMBL28813769 | 0.85 | MEN1 (0.33) | MEN1KMT2A | |
| SCHEMBL11263233 | 0.85 | MEN1 (0.33) | MEN1KMT2A | |
| SCHEMBL30805 | 0.85 | MEN1 (0.33) | MEN1KMT2A | |
| SCHEMBL1892052 | 0.85 | TSHR (0.36) | OSBPOSBP2MEN1KMT2A | |
| SCHEMBL26906219 | 0.85 | TSHR (0.36) | OSBPOSBP2MEN1KMT2A | |
| SCHEMBL13735469 | 0.83 | OSBP (0.30) | OSBPOSBP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1786913-B1 | METHOD FOR THE PRODUCTION OF DIARYLCYCLOALKYL DERIVATIVES | SANOFI AVENTIS DEUTSCHLAND (DE) | 2011-08-17 | — | — | EP | disclosed |
| US-7803950-B2 | Method for the production of diarylcycloalkyl derivatives | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2010-09-28 | — | — | US | disclosed |
| CN-100556959-C | Dichroic mixtures | ROLIC AG (CH) | 2009-11-04 | — | — | CN | disclosed |
| US-20080051583-A1 | NOVEL INTERMEDIATE COMPOUNDS USEFUL IN THE PRODUCTION OF DIARYLCYCLOALKYL DERIVATIVES | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2008-02-28 | — | — | US | disclosed |
| US-20070197614-A1 | METHOD FOR THE PRODUCTION OF DIARYLCYCLOALKYL DERIVATIVES | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2007-08-23 | — | — | US | disclosed |
| EP-1319197-B1 | ANTIREFLECTIVE COMPOSITION | SHIPLEY CO LLC (US) | 2007-06-06 | — | — | EP | disclosed |
| CN-1507478-A | Dichroic mixture | — | 2004-06-23 | — | — | CN | disclosed |
| WO-2002023274-A9 | PHOTORESIST COMPOSITION | SHIPLEY CO LLC (US) | 2003-11-13 | — | — | WO | disclosed |
| US-6645695-B2 | Crosslinked polymeric particles and a photoactive component, wherein the polymeric particles comprise cleavable group(s); free of surfactant; forming relief images | SHIPLEY COMPANY, L.L.C. | 2003-11-11 | — | — | US | disclosed |
| EP-1319197-A2 | ANTIREFLECTIVE COMPOSITION | Shipley Company LLC (US) | 2003-06-18 | — | — | EP | disclosed |
| US-6503689-B2 | Crosslinked polymeric particles including one or more chromophore units such as anthracenyl methacrylate; relief images | SHIPLEY COMPANY, L.L.C. | 2003-01-07 | — | — | US | disclosed |
| US-20020076642-A1 | Antireflective composition | SHIPLEY COMPANY, L.L.C. | 2002-06-20 | — | — | US | disclosed |
| US-20020051928-A1 | Photoresist composition | SHIPLEY COMPANY, L.L.C. (US) | 2002-05-02 | — | — | US | disclosed |
| WO-2002025374-A2 | ANTIREFLECTIVE COMPOSITION | SHIPLEY COMPANY, L.L.C. (US) | 2002-03-28 | — | — | WO | disclosed |
| WO-2002023274-A2 | PHOTORESIST COMPOSITION | SHIPLEY COMPANY, L.L.C. (US) | 2002-03-21 | — | — | WO | disclosed |
| US-5945517-A | CAPABLE OF GIVING A PATTERNED RESIST LAYER WITH HIGH CONTRAST, HIGH FILM THICKNESS RETENTION, HIGH PATTERN RESOLUTION AND LATENT IMAGE STABILITY | TOKYO OHKA KOGYO CO., LTD. (JP) | 1999-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080051583-A1 | NOVEL INTERMEDIATE COMPOUNDS USEFUL IN THE PRODUCTION OF DIARYLCYCLOALKYL DERIVATIVES | PPARG, PPARD, PPARA | OSBP 1189/4885OSBP2 2436/4885MEN1 4680/4885 |
| US-20070197614-A1 | METHOD FOR THE PRODUCTION OF DIARYLCYCLOALKYL DERIVATIVES | PPARA, PPARD, PPARG | OSBP 1000/4885OSBP2 2243/4885MEN1 4720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.